BMS-279700 is a potent oral activity inhibitor that is part of a new family of aniline 5-azimidazolaquoxaline analogs and has excellent anti-inflammatory activity in vivo, as well as in vitro activity against p56LCK and T cell proliferation, blocking the production of pro-inflammatory cytokines (IL-2 and TNFalpha) in vivo.
Molecular Weight:
407.9
CAS Number:
[240814-54-4]
Formula:
C21H22ClN7
Target:
Others
T30511
* VAT and and shipping costs not included. Errors and price changes excepted
